DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Epivir (Lamivudine) - Adverse Event Reports - Hospitalization - Anaemia

 



Index of reports > Cases resulting in hospitalization (92) > Cases with Anaemia (11)

Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in hospitalization where reactions include anaemia.

Adverse event in 33 year old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-04-03

Patient: 33 year old male

Adverse reactions / side effects: Drug Eruption, Anaemia, Glucose Tolerance Impaired

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Epivir
    Dosage: 300mg per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-09-13

Combivir
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-10-19
    End date: 2005-01-11

Zerit
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-09-13
    End date: 2004-10-18

Viramune
    Dosage: 400mg per day
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-09-13
    End date: 2004-09-26

Kaletra
    Administration route: Oral
    Indication: Acquired Immunodeficiency Syndrome
    Start date: 2004-09-27
    End date: 2004-10-18

Other drugs received by patient: Stocrin; Viread; Clarithromycin; Baktar; Unknown Drug; Ciprofloxacin; Ebutol



Adverse event in male receiving Epivir (Lamivudine)

Reported by a physician from United States on 2007-03-30

Patient: male

Adverse reactions / side effects: Anaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Efavirenz
    Administration route: Oral
    Start date: 2006-10-01
    End date: 2007-01-01

Epivir
    Administration route: Oral
    Start date: 2006-10-01
    End date: 2007-01-01

Retrovir
    Administration route: Oral
    Start date: 2006-10-01
    End date: 2007-01-01



Adverse event in female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-03-05

Patient: female

Adverse reactions / side effects: Cleft LIP and Palate, Anaemia, Drug Exposure VIA Breast Milk

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Indication: HIV Infection
    Start date: 2004-02-13

Retrovir
    Indication: HIV Infection
    Start date: 2004-02-13

Viracept
    Indication: HIV Infection
    Start date: 2004-02-13

Retrovir
    Dosage: .46ml four times per day
    Administration route: Oral
    Start date: 2004-06-22
    End date: 2004-08-03

Other drugs received by patient: Espo; Espo



Adverse event in 65 year old female receiving Epivir (Lamivudine)

Reported by a physician from United States on 2007-03-02

Patient: 65 year old female

Adverse reactions / side effects: Anaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Prezista
    Administration route: Oral
    Indication: HIV Infection

Norvir
    Indication: HIV Infection

Mk0518
    Administration route: Oral
    Indication: HIV Infection

Epivir
    Indication: HIV Infection

Prezista
    Administration route: Oral
    Indication: HIV Infection

Norvir
    Indication: HIV Infection

Mk0518
    Administration route: Oral
    Indication: HIV Infection

Epivir
    Indication: HIV Infection

Other drugs received by patient: Norvasc; Prednisone; Valcyte; Calcium Carbonate; Vitamin D; Magnesium; Imodium; Bactrim DS; Coumadin; Alinia; Fluconazole; Nexium; Iron; Neurontin; Azithromycin; Norvasc; Prednisone; Valcyte; Calcium Carbonate; Vitamin D; Magnesium; Imodium; Bactrim DS; Coumadin; Alinia; Fluconazole; Nexium; Iron; Neurontin; Azithromycin



Adverse event in male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from Japan on 2007-02-28

Patient: male

Adverse reactions / side effects: Anaemia, Epilepsy

Adverse event resulted in: hospitalization

Suspect drug(s):
Viramune
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-23

Nevirapine
    Administration route: Oral
    Start date: 2004-09-25
    End date: 2004-09-25

Retrovir
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Zidovudine
    Start date: 2004-09-23
    End date: 2004-11-18

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Lamivudine
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18

Nelfinavir Mesilate
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18



Adverse event in 75 year old female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-02-22

Patient: 75 year old female

Adverse reactions / side effects: Anaemia, Chest Pain

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-11-26
    End date: 2005-06-14

Viread
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2002-10-01
    End date: 2005-06-14

Norvir
    Dosage: 100mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-02-27

Reyataz
    Dosage: 300mg per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-02-27

Other drugs received by patient: Blopress; Adalat; Cibenol; Aspirin; Frandol S; Baktar; Adalat; Herbesser; Truvada; Nitroderm; Warfarin Sodium; Gaster D; Dogmatyl



Adverse event in male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from Japan on 2007-02-01

Patient: male

Adverse reactions / side effects: Anaemia, Epilepsy

Adverse event resulted in: hospitalization

Suspect drug(s):
Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-23

Nevirapine
    Administration route: Oral
    Start date: 2004-09-25
    End date: 2004-09-25

Retrovir
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Zidovudine
    Start date: 2004-09-23
    End date: 2004-11-18

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Lamivudine
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18

Nelfinavir Mesilate
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18



Adverse event in female receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-01-29

Patient: female

Adverse reactions / side effects: Cleft LIP and Palate, Anaemia, Drug Exposure VIA Breast Milk

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Dosage: 150mg twice per day
    Start date: 2004-02-13

Retrovir
    Start date: 2004-02-13

Viracept
    Start date: 2004-02-13

Retrovir
    Dosage: .46ml four times per day
    Administration route: Oral
    Start date: 2004-06-22
    End date: 2004-08-03

Other drugs received by patient: Espo; Espo



Adverse event in 6 month old male receiving Epivir (Lamivudine)

Reported by a physician from Japan on 2007-01-25

Patient: 6 month old male, weighing 2.5 kg (5.5 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Anaemia, Epilepsy

Adverse event resulted in: hospitalization

Suspect drug(s):
Epivir
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18

Retrovir
    Dosage: .38ml per day
    Start date: 2004-09-23
    End date: 2004-09-24

Retrovir
    Administration route: Oral
    Start date: 2004-09-26
    End date: 2004-11-18

Retrovir
    Dosage: .7ml three times per day
    Administration route: Oral
    Start date: 2004-10-26
    End date: 2004-11-18

Epivir
    Dosage: 400mg per day
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Retrovir
    Dosage: 300mg per day
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Viramune
    Start date: 2004-09-22
    End date: 2004-09-23

Viracept
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18

Viracept
    Dosage: 280mg twice per day
    Administration route: Oral
    Start date: 2004-10-26
    End date: 2004-11-18

Marijuana

Other drugs received by patient: Viramune; Bactrim; Espo; Glucose; Glucose



Adverse event in male receiving Epivir (Lamivudine)

Reported by a individual with unspecified qualification from Japan on 2007-01-24

Patient: male

Adverse reactions / side effects: Anaemia, Epilepsy

Adverse event resulted in: hospitalization

Suspect drug(s):
Viramune
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-23

Nevirapine
    Administration route: Oral
    Start date: 2004-09-25
    End date: 2004-09-25

Retrovir
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Zidovudine
    Start date: 2004-09-23
    End date: 2004-11-18

Epivir
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2004-09-22
    End date: 2004-09-30

Lamivudine
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18

Nelfinavir Mesilate
    Administration route: Oral
    Start date: 2004-09-28
    End date: 2004-11-18



Adverse event in female receiving Epivir (Lamivudine)

Reported by a consumer/non-health professional from United States on 2007-01-12

Patient: female

Adverse reactions / side effects: Anaemia, Thrombocythaemia, Pregnancy, Blood Lactic Acid Increased, Hypertriglyceridaemia

Adverse event resulted in: hospitalization

Suspect drug(s):
Zerit
    Administration route: Oral
    Start date: 1999-02-19

Viracept
    Administration route: Oral
    Indication: HIV Infection
    Start date: 1999-02-19

Retrovir
    Indication: HIV Test Positive
    Start date: 1999-02-19

Epivir
    Administration route: Oral
    Start date: 1999-02-19

Other drugs received by patient: Methadone HCL

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009